BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Strosberg JR, Fisher GA, Benson AB, Anthony LB, Arslan B, Gibbs JF, Greeno E, Iyer RV, Kim MK, Maples WJ, Philip PA, Wolin EM, Cherepanov D, Broder MS. Appropriateness of systemic treatments in unresectable metastatic well-differentiated pancreatic neuroendocrine tumors. World J Gastroenterol 2015; 21(8): 2450-2459 [PMID: 25741154 DOI: 10.3748/wjg.v21.i8.2450]
URL: https://www.wjgnet.com/1007-9327/full/v21/i8/2450.htm
Number Citing Articles
1
Giuseppe Aprile, Karim Rihawi, Elisa De Carlo, Stephen T Sonis. Treatment-related gastrointestinal toxicities and advanced colorectal or pancreatic cancer: A critical updateWorld Journal of Gastroenterology 2015; 21(41): 11793-11803 doi: 10.3748/wjg.v21.i41.11793
2
Qiaohua Xu, Biyun Chen, Donghui Jin, Li Yin, Yuelong Huang. An assessment for health education and health promotion in chronic disease demonstration districts: a comparative study from Hunan Province, ChinaPeerJ 2019; 7: e6579 doi: 10.7717/peerj.6579
3
Elettra Merola, Francesco Panzuto, Gianfranco Delle Fave. Antiproliferative effect of somatostatin analogs in advanced gastro-entero-pancreatic neuroendocrine tumors: a systematic review and meta-analysisOncotarget 2017; 8(28): 46624 doi: 10.18632/oncotarget.16686
4
Marco Gallo, Pasqualino Malandrino, Giuseppe Fanciulli, Francesca Rota, Antongiulio Faggiano, Annamaria Colao. Everolimus as first line therapy for pancreatic neuroendocrine tumours: current knowledge and future perspectivesJournal of Cancer Research and Clinical Oncology 2017; 143(7): 1209 doi: 10.1007/s00432-017-2407-5
5
Teresa Alonso-Gordoa, Juan José Díez, Javier Molina, Pablo Reguera, Olga Martínez-Sáez, Enrique Grande. An Overview on the Sequential Treatment of Pancreatic Neuroendocrine Tumors (pNETs)Rare Cancers and Therapy 2015; 3(1-2): 13 doi: 10.1007/s40487-015-0007-6
6
Eliza B. Geer, Alejandro Ayala, Vivien Bonert, John D. Carmichael, Murray B. Gordon, Laurence Katznelson, Ekaterina Manuylova, Ismat Shafiq, Vijaya Surampudi, Ronald S. Swerdloff, Michael S. Broder, Dasha Cherepanov, Marianne Eagan, Jackie Lee, Qayyim Said, Maureen P. Neary, Beverly M. K. Biller. Follow-up intervals in patients with Cushing’s disease: recommendations from a panel of experienced pituitary cliniciansPituitary 2017; 20(4): 422 doi: 10.1007/s11102-017-0801-2
7
Pei-Jung Chiang, Tsai-Chung Li, Chih-Hung Chang, Li-Li Chen, Jun-Dai Lin, Yi-Chang Su. SEED: the six excesses (Liu Yin) evaluation and diagnosis scaleChinese Medicine 2015; 10(1) doi: 10.1186/s13020-015-0059-4
8
Jeffery Chakedis, Eliza W. Beal, Alexandra G. Lopez-Aguiar, George Poultsides, Eleftherios Makris, Flavio G. Rocha, Zaheer Kanji, Sharon Weber, Alexander Fisher, Ryan Fields, Bradley A. Krasnick, Kamran Idrees, Paula Marincola-Smith, Clifford Cho, Megan Beems, Timothy M. Pawlik, Shishir K Maithel, Carl R. Schmidt, Mary Dillhoff. Surgery Provides Long-Term Survival in Patients with Metastatic Neuroendocrine Tumors Undergoing Resection for Non-Hormonal SymptomsJournal of Gastrointestinal Surgery 2019; 23(1): 122 doi: 10.1007/s11605-018-3986-4
9
Vladimir Neychev, Electron Kebebew. Management Options for Advanced Low or Intermediate Grade Gastroenteropancreatic Neuroendocrine Tumors: Review of Recent LiteratureInternational Journal of Surgical Oncology 2017; 2017: 1 doi: 10.1155/2017/6424812